DialBetics: A Novel Smartphone-based Self-management Support System for Type 2 Diabetes Patients
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background: Numerous diabetes-management systems and programs for improving glycemic control to meet guideline targets have been proposed, using IT technology. But all of them allow only limited—or no—real-time interaction between patients and the system in terms of system response to patient input; few studies have effectively assessed the systems’ usability and feasibility to determine how well patients understand and can adopt the technology involved. Method: DialBetics is composed of 4 modules: (1) data transmission module, (2) evaluation module, (3) communication module, and (4) dietary evaluation module. A 3-month randomized study was designed to assess the safety and usability of a remote health-data monitoring system, and especially its impact on modifying patient lifestyles to improve diabetes self-management and, thus, clinical outcomes. Fifty-four type 2 diabetes patients were randomly divided into 2 groups, 27 in the DialBetics group and 27 in the non-DialBetics control group. Results: HbA1c and fasting blood sugar (FBS) values declined significantly in the DialBetics group: HbA1c decreased an average of 0.4% (from 7.1 ± 1.0% to 6.7 ± 0.7%) compared with an average increase of 0.1% in the non-DialBetics group (from 7.0 ± 0.9% to 7.1 ± 1.1%) ( P = .015); The DialBetics group FBS decreased an average of 5.5 mg/dl compared with a non-DialBetics group average increase of 16.9 mg/dl ( P = .019). BMI improvement—although not statistically significant because of the small sample size—was greater in the DialBetics group. Conclusions: DialBetics was shown to be a feasible and an effective tool for improving HbA1c by providing patients with real-time support based on their measurements and inputs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various mobile technologies and digital health interventions (DHIs) have been developed for type 2 diabetes mellitus (T2DM) management.”
From Assessing the Effectiveness of Digital Health Behavior Strategies on Type 2 Diabetes Management: Systematic Review and Network Meta-Analysis (2025) · cites this paper as [18]
In the citing paper
“Various mobile technologies (ie, mobile health care) and digital health interventions (DHIs) have been developed [15-18], including mobile apps, SMS, wearable and ambient sensors, and social media.”
From Assessing the Effectiveness of Digital Health Behavior Strategies on Type 2 Diabetes Management: Systematic Review and Network Meta-Analysis (2025) · cites this paper as [18]
In the citing paper
“Of 11 studies that included control groups in their study design, 7 studies reported significant differences (mean difference: –0.78%, –1.51 to –0.35) in favor of the app intervention groups [51,53-58]”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [57]
In the citing paper
“12 were focused on T2DM (743 patients in the intervention groups and 645 patients in the control groups) [50-61]”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [57]
In the citing paper
“Eleven of the studies reported a decrease of HbA1c within the app intervention groups, yielding a mean difference of –0.42% [50-52,54-61], but only 1 study reported a significant change of –1.1% (P<.001) [56].”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [57]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
National Health and Nutrition Examination Survey
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6177 · Cited by 2,087
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Research works printed but not linked: 2
- Aramaki E, 2008, Int Joint Conference Nat Lang Processing, 2008, 48
- 10.1097/MAJ.0b013e3182896cee · DOI · Paper page
Cited by
Whitehead, L., & Seaton, P. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4883 · Cited by 743
“Only 3 studies [22,27,28] reported an inbuilt safety mechanism for the app intervention, whereby a reading outside of the normal range and considered aberrant enough according to the inbuilt logarithm would trigger an alert.”
BackgroundMethodResultInfluentialHou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Wu, Y., Yao, X., Vespasiani, G., Nicolucci, A., Dong, Y., Kwong, J., Li, L., Sun, X., Tian, H., & Li, S. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.6522 · Cited by 283
“Table 2 summarizes the modules, risks, and technologies of the mobile app-based interventions included in the meta-analysis [37-49].”
Wu, X., Guo, X., & Zhang, Z. (2019) · JMIR mHealth and uHealth · doi:10.2196/12297 · Cited by 249
“Of the 18 studies eligible for meta-analysis, 5 [20-24] examined T1DM, 11 [25-35] examined T2DM, and 2 [36,37] examined prediabetes.”
Influential
Metadata
- Authors
- Waki, K., Fujita, H., Uchimura, Y., Omae, K., Aramaki, E., Kato, S., Lee, H., Kobayashi, H., Kadowaki, T., & Ohe, K.
- Affiliations
- The University of Tokyo (JP)
- NTT (Japan) (JP)
- ORCID
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2014-03
- Volume
- 8
- Issue
- 2
- Pages
- 209-215
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC4455411
- OpenAlex
- W2100476420
- Cited by
- 203
- References
- 22
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 17 · 2023: 17 · 2022: 16 · 2021: 26 · 2020: 20 · 2019: 22 · 2018: 26 · 2017: 19 · 2016: 13 · 2015: 10 · 2014: 2
- FWCI
- 26.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23790559)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, diabetes self-management, remote patient monitoring, glycemic control, HbA1c, fasting blood glucose, dietary assessment, usability, telemedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DialBetics: A Novel Smartphone-based Self-management Support System for Type 2 Diabetes Patients. https://app.cochat.ai/papers/10.1177/1932296814526495
- The paper
- Waki, K., Fujita, H., Uchimura, Y., Omae, K., Aramaki, E., Kato, S., Lee, H., Kobayashi, H., Kadowaki, T., & Ohe, K. (2014). DialBetics: A Novel Smartphone-based Self-management Support System for Type 2 Diabetes Patients. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296814526495
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.